RaDIANT Health Systems Intervention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIndiana University
About this trial
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Eligibility criteria
Qualifiers
Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) ~800 referring dialysis center referring to these transplant centers
Disqualifiers
Individuals referred, initiating evaluation, and waitlisted at non-participating start centers
Trial design
Treatments tested in this trial
- Performance Feedback Reports on Referral and Evaluation Closures
- Dialysis Facility Awareness Campaign
- Patient Contact via Preferred Method
- Phone Call to Dialysis Facility During the Patient's Dialysis Session
- Phone Call to Provider
- Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show
- Audit and Tracking of Patient Contact Attempts Prior to Referral Closure
Treatment groups
14,000 Participants
are divided into 1 treatment groupLocations
5Emory Transplant Center30322, AtlantaGeorgia, United States
Piedmont Transplant Institute30309, AtlantaGeorgia, United States
IU Health Transplant - Indianapolis46202, IndianapolisIndiana, United States
Duke Transplant Center27710, DurhamNorth Carolina, United States
Sponsors and collaborators
Indiana University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Indiana University Health
Collaborator
Emory Healthcare
Collaborator
Piedmont Healthcare
Collaborator
Medical University of South Carolina
Collaborator
Duke University
Collaborator
Source ClinicalTrials.gov